Company intelligence / Profile preview

VasoNova

Silicon Valley/Palo Alto area, California, United Statesteleflexvascular.com ↗

Ownership: Private
Development stage: Commercial

Overview

Developed a real-time catheter tip positioning technology using ECG and Doppler ultrasound data with computer algorithms. The system achieved near 100% accuracy for confirming catheter tip location in the lower third of the superior vena cava. FDA approved as an alternative to x-ray confirmation for PICC/CVC placement in 2011. Technology was commercialized as VPS under Teleflex after acquisition.

Therapeutic areas: Cardiovascular
Modalities: DeviceAlgorithm-based guidance system (combining Doppler ultrasound and electrocardiography)
Industry: Medical Imaging

Partnerships

No major external partnerships disclosed prior to acquisition; post-acquisition technology marketed by Teleflex.

Beyond the preview

Go deeper on VasoNova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VasoNova.

Explore the full profile